Abstract Cardiomyopathies are myocardial diseases that lead to cardiac dysfunction, heart failure, arrhythmia, and sudden death. In human medicine, cardiomyopathies frequently warrant heart transplantation in children and adults. Bovine dilated cardiomyopathy (BDCMP) is a heart muscle disorder that has been observed during the last 30 years in cattle of Holstein-Friesian origin. In Switzerland BDCMP affects Swiss Fleckvieh and Red Holstein breeds. BDCMP is characterized by a cardiac enlargement with ventricular remodeling and chamber dilatation. The common symptoms in affected animals are subacute subcutaneous edema, congestion of the jugular veins, and tachycardia with gallop rhythm. A cardiomegaly with dilatation and hypertrophy of all heart chambers, myocardial degeneration, and fibrosis are typical postmortem findings. It was shown that all BDCMP cases reported worldwide traced back to a red factor-carrying HolsteinFriesian bull, ABC Reflection Sovereign. An autosomal recessive mode of inheritance was proposed for BDCMP. Recently, the disease locus was mapped to a 6.7-Mb interval MSBDCMP06-BMS2785 on bovine Chr 18 (BTA18). In the present study the BDCMP locus was fine mapped by using a combined strategy of homozygosity mapping and association study. A BAC contig of 2.9 Mb encompassing the crucial interval was constructed to establish the correct marker order on BTA18. We show that the disease locus is located in a gene-rich interval of 1.0 Mb and is flanked by the microsatellite markers DIK3006 and MSBDCMP51.
Introduction
Cardiomyopathies are diseases of the myocardium associated with cardiac dysfunction. In human medicine they are classified as dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy (Richardson et al. 1996) . Many conditions characteristic for one form of a cardiomyopathy may progress to another condition. Cardiomyopathy frequently results in heart failure, arrhythmia, and sudden death. The histologic findings in such a dysfunctional myocardium are nonspecific, with hypertrophic myocytes, cellular necrosis, and fibrosis.
Bovine dilated cardiomyopathy (BDCMP) is a primary disease of the heart muscle observed worldwide in Holstein-Friesian cattle during the last 30 years. In Switzerland the introduction of Red Holstein genetics into the Simmental population began in 1968. These crosses are referred to as Fleckvieh and form a section apart from Simmental and Red Holstein. BDCMP affects Fleckvieh and Red Holstein cattle but not the Simmental cattle of the Swiss Fleckvieh breed (Graber and Martig 1993; Martig 1992; Martig et al. 1982) . The disease is characterized by a global cardiac enlargement and ventricular remodeling leading to a chamber dilatation with decreased wall thickness and a diminution in systolic function. A subacute subcutaneous edema within the brisket and to a lesser extent in the mandibular and the ventral abdominal region is usually observed. Moreover, an increased pulse rate, up to 140 beats/min, tachycardia with gallop rhythm of the heart, and congestion of the jugular veins are common in affected animals. The typical age at onset of BDCMP is between 2 and 4 years but BDCMP was also diagnosed in calves younger than 2 months and in cows older than 8 years (Graber and Martig 1993; Martig 1992; Martig and Reusser 1988) . Although BDCMP is a slowly progressive terminal disease, distinct clinical symptoms develop within a few days or weeks and all affected animals die or have to be culled shortly after disease onset (Bradley et al. 1991; Danzl 1995; Kümper and Bahnemann 1992; Martig and Tschudi 1985; Martig et al. 1982; McLennan and Kelly 1990; Sonoda et al. 1982; Tontis et al. 1990 ). Initially, cardiomyocyte necrosis in all parts of the heart followed by transmural fibrosis often occurs (König et al. 1990 ). First, the left ventricle fails to compensate, leading to pulmonary hypertension, followed by hypertrophy of the right ventricle, which finally causes the clinically manifest right heart failure (Lobsiger et al. 1985; Martig and Tschudi 1985) . BDCMP can be easily misdiagnosed as traumatic pericarditis or valvular endocarditis (Martig et al. 1982) . The pathologic findings are cardiomegaly with an extensive dilatation and hypertrophy of all sections of the myocardium, as well as myocardial fibrosis, partially accompanied by myofibrillar degeneration. To date, there is no treatment known for BDCMP.
All reported cases in Canada (Baird et al. 1986 ), Japan (Satoh 1988) , and Switzerland (Martig and Reusser 1988; Martig et al. 1982) were traced back to a red factor-carrying Holstein-Friesian bull, ABC Reflection Sovereign, which strongly suggests a hereditary nature of the disease. A segregation analysis based on an experimental BDCMP pedigree confirmed the genetic basis of an autosomal recessive mode of inheritance for the disease (Dolf et al. 1998) . Recently, BDCMP cases were reported in Denmark (Leifsson and Agerholm 2004) . BDCMP is periodically diagnosed in slaughterhouses in Switzerland, but the frequency of the mutant allele responsible for the disease remains unknown.
The locus for bovine dilated cardiomyopathy was mapped to Chr 18 (BTA18) in the MSBDCMP06-BMS2785 interval (Guziewicz et al. 2007 ). In present study we fine-mapped the BDCMP locus to a 1.0-Mb interval by a combined homozygosity mapping and association-based strategy. BAC clones screening BAC DNA from clones of the CHORI BAC library was tested by PCR. BAC DNA pools from the INRA BAC library were first PCR-screened and subsequently positive clones were examined by PCR-based strategy for the presence of specific markers and genes. The PCR amplification mixture contained 1.5 ll of BAC DNA (25 ng), 0.4 ll of the primer (10 pmol/ll, forward and reverse, respectively), 0.2 ll of dNTPs mix (5 mM), 1 ll of 10 9 PCR buffer, and 0.05 ll of AmpliTaqGold polymerase (5 U/ll), and deionized water was added to a final volume of 10 ll (Applied Biosystems, Rotkreuz, Switzerland). The amplification was performed with an initial denaturation step at 95°C for 20 min, followed by 30 cycles with a denaturation step at 94°C for 30 sec, an annealing step at 60°C for 1 min, an extension step at 72°C for 2 min, and a final extension phase at 72°C for 10 min.
Material and methods

BAC libraries
The amplicons were separated on 1% agarose gels, stained with ethidium bromide, and visualized under UV light. Primer pairs were designed with the PRIMER3 software and are listed in Supplementary Table 1. To screen BAC clones, 20 microsatellite markers, 7 PCR products with known location on BTA18, and 27 PCR products of orthologous genes located on human counterpart Chr 19 (HSA19) were used. DNA extraction DNA from 49 blood samples was isolated using Chelex Ò 100 (BioRad, Reinach BL, Switzerland) or a High Pure PCR Template Purification Kit (Roche Diagnostics, Rotkreuz, Switzerland). DNA from 304 formalin-fixed and thereafter paraffin-embedded myocardial samples from BDCMP-affected animals was isolated and purified using a DNeasy Blood & Tissue Kit (Qiagen, Hombrechtikon, Switzerland).
Genotyping with microsatellite markers
In the present study, samples from 353 animals were genotyped for 24 microsatellite markers (MS) in the interval between MSBDCMP06 and BMS2785, whereof 9 were selected from publically available data and 15 represent newly developed markers taken from the bovine genome sequence assembly Btau 4.0 (Supplementary Table 2 ).
The volume of a multiplex amplification reaction was 10 ll and contained 2 ll of DNA (20 ng), 0.2 ll of each primer (10 pmol/ll, forward and reverse, respectively), 5 ll of Multiplex PCR Master Mix (Qiagen), and 1 ll of 5 9 Q-solution. Water was added to reach the final volume. Most of the multiplex reactions contained a combination of five different primer pairs. The PCR was conducted under the following conditions: initial denaturation step at 95°C for 15 min, 30 cycles with a denaturation step at 94°C for 30 sec, an annealing step at 60°C for 1 min, and an extension step at 72°C for 45 sec. The final extension step was carried out for 30 min at 60°C. PCR products were initially examined on 2% agarose gels and, subsequently, 1 ll of each PCR was combined with 10 ll of genotyping mix (980 ll of HiDi formamide and 20 ll of GeneScan TM -500 LIZ TM Size Standard, Applied Biosystems). After a 2-min denaturation at 95°C and chilling on ice, samples were genotyped on an ABI 3730 capillary sequencer (Applied Biosystems). The data were processed using the GeneMapper Ò software ver. 4.0 (Applied Biosystems).
SNP genotyping
Annotated SNPs (http://www.ncbi.nlm.nih.gov/sites/entrez? db=snp) were selected according to their location within the interval of interest on BTA18. Additional SNP markers were developed in order to increase the marker density in the critical interval. These SNPs in the 1.0-Mb region between microsatellites markers DIK3006 and MSBDCMP51 flanked by the distal genes APOE and NPAS1 were genotyped using a panel of 18 BDCMP-affected animals and 18 controls. In total, 38 PCR products were obtained according to standard protocols (Supplementary Table 3 ). These 38 PCR products each contained one to eight SNPs resulting in a total of 123 SNPs. Amplicons were purified with rAPid alkaline phosphatase (Roche) and exounuclease I (N.E.B., Bioconcept, Allschwil, Switzerland). Both strands were directly sequenced on an ABI 3730 capillary sequencer (Applied Biosystem) using the BigDye Ò Terminator Cycling Kit (Applied Biosystems). Sequencing data were analyzed using the Sequencher 4.8 software (Gene Codes Corporation, Ann Arbor, MI, USA).
Statistical analysis
The statistical analysis including genotypes of 123 SNP markers was initially performed with SAS Genetics 9.1.3 software (SAS Institute Inc., Cary, NC, USA) using the procedure allele. The established minor allele frequency (MAF) was 20%. In total, 86 SNP markers were analyzed with the SAS Genetics 9.1.3 software procedure casecontrol and with the Haploview 4.0 software (Barrett et al. 2005) (http://www.broad.mit.edu/mpg/haploview/download.php). A permutation test was carried out with 1000 permutations and the single marker procedure was selected.
Results and discussion
BAC contig construction
The comparison between the cattle and the human maps revealed that the critical region on bovine Chr 18 (BTA18q) is homologous to human Chr 19 (HAS19) (Guziewicz 2004) . Recently, Guziewicz et al. (2007) demonstrated in an experimental pedigree segregating for BDCMP that the disease locus maps to a 6.7-Mb region encompassed by MS markers MSBDCMP06 and BMS2785 on BTA18 (Btau 3.1). This interval corresponds now to 5.6 Mb in the bovine genome sequence assembly Btau 4.0. The publicly available BAC contig listing of bovine CHORI BACs was initially used to build the contig around the BDCMP locus. Although the information of the overlapping genomic sequence was indicated in the BAC contig provided by the bovine genome project, several overlaps could not be verified by PCR-based STS content mapping. Therefore, additional BAC clones were introduced from the INRA bovine BAC library in the attempt to close the remaining gaps. The combination of clones from the two BAC libraries allowed us to construct a 2.9-Mb BAC contig spanning the interval between MS markers MSBDCMP22 and BMS2785 (Fig. 1b) . The minimal tiling path of this contig consists of 23 tiled BAC clones. We found that the gene order on a chromosomal segment between positions 51.11 and 52.12 Mb was inverted in Btau 3.1 as compared to our BAC contig and the human counterpart HSA19. This finding was then fully confirmed in the recent cattle genome assembly (Btau 4.0), where the gene order in the critical interval is in agreement with that in our BAC contig and human Chr 19. The BAC contig is an excellent tool toward fine mapping the critical interval, to map the DNA markers, and to explore the still existing and numerous DNA sequence gaps in the present version of the bovine genome.
Homozygosity mapping of the BDCMP locus
This approach aims to identify the autosomal recessive disease-causing locus by virtue of the fact that the adjacent DNA sequence is homozygous by descent. It is evident that all BDCMP-affected animals in the Swiss Fleckvieh population trace back to the Canadian bull ABC Reflection Sovereign (Dolf et al. 1998) . Therefore, alleles adjacent to the BDCMP locus are considered identical by descent and share extended haplotypes. In an initial step 25 BDCMPaffected and 24 unaffected Fleckvieh animals were genotyped with nine MS markers randomly distributed within the interval between MS markers MSBDCMP06 and BMS2785, previously defined by Guziewicz et al. (2007) . All the affected animals were homozygous at the markers MSBDCMP22, DIK3006, DIK3014, MSBDCMP25, and RME01 supporting the hypothesized identity by descent. Chromosomes were considered recombinant for an individual that is heterozygous for markers located distal of the interval MSBDCMP06-BMS2785 and homozygous for adjacent markers located within this interval. We found 11 presumably recombinant chromosomes on the centromeric site and 9 on the telomeric site of the interval MSBDCMP06-BMS2785. This homozygosity mapping narrowed the critical interval down to about 4.1 Mb between markers MSBDCMP06 and MSBDCMP51. An additional 15 evenly distributed MS markers were selected within the interval MSBDCMP06-BMS2785 based on the bovine genome sequence assembly Btau 4.0. The markers were chosen so that they were evenly distributed in the interval. DNA from 304 paraffin-embedded heart tissue samples of cattle with a positive BDCMP diagnosis, including some cases with uncertain diagnoses, were available for genotyping. The advantage of these paraffinembedded samples is that the BDCMP diagnosis can be reevaluated based on histologic criteria by an experienced pathologist. Furthermore, these paraffin-embedded samples were collected during a period of about 20 years at two different locations in Switzerland and the BDCMP animals were originally diagnosed by different pathologists. The reevaluation is important as BDCMP can be easily misdiagnosed. We genotyped all these samples with 24 MS markers in the interval MSBDCMP06-BMS2785. The identification of an additional 3 and 18 recombinant chromosomes from the centromeric and telomeric side, respectively, allowed us to reduce the critical interval from 4.1 to 1.0 Mb. The current 1.0-Mb interval is flanked by MS markers DIK3006 and MSBDCMP51 (Fig. 1a) . It is striking that the BDCMP-affected animals, previously assumed to be unrelated, are all homozygous for the markers that were also homozygous in the BDCMP animals in the experimental pedigree. This finding strongly indicates that indeed all affected animals are descendents from a single founder animal.
Association study
In this study we combined homozygosity mapping with an association-based strategy to further fine map the BDCMP locus in the interval between MS DIK3006 and MSBDCMP51 (Fig. 1a) . We included on each distal site of this interval additional SNP markers located in APOE and NPAS1 genes, respectively. The association study was performed including these markers and indicates that the region outside of DIK3006 and MSBDCMP51 is not associated with BDCMP. In this interval a total of 36 PCR products containing one to eight SNP markers were genotyped by means of DNA sequencing for 18 BDCMPaffected and 18 unaffected animals. In addition, two families comprising eight individuals from the experimental pedigree were included in the genotyping procedure to deduce the disease haplotype. BAC clones were tested by PCR to map the SNP markers to our BAC contig. However, one of these PCR products containing six SNPs (Supplementary Table 3 ) was thereafter excluded from the association study because we could not amplify it on any of the BAC clones. This emphasizes that the BAC contig can be a useful tool in the fine mapping of disease genes.
The association study was initially performed using SAS Genetics software. A minimal MAF of 20% was applied in the analysis resulting in the exclusion of 31 SNP markers. The SNP in NPAS1 gene was therefore excluded from the final analysis and is not presented in Fig. 1c . The genotypes of 86 remaining SNP markers were thereafter analyzed using the Haploview 4.0 software. The best observed v 2 was 60.4 and the best permutation v 2 (1000 permutations, single marker) was 21.4. The analyses revealed significant association between markers and disease over the whole interval DIK3006-MSBDCMP51 and showed three highly associated regions (Fig. 1c) .
The human HSA19 counterpart of this 1.0-Mb interval corresponds to a region between 50. 50 and 52.11 Mb (Build 36.6 ). This is a gene-rich region and contains 47 genes and 18 annotated hypothetical loci. In the mouse this region was found on Chr 7 (MMU7) between 17.07 and 19.99 Mb (Build 37.1) but the gene order is inverted compared to that in human and cattle.
An in silico evaluation showed that among 47 genes on HSA19, CKM, VASP, PPP1R13L, DMPK, and AP2S1 genes are highly expressed in the cardiovascular system; moderately expressed are the GIPR, PNMAL2, and GRLF1 genes, and GPR4, IGFL3, HIF3A, PRKD2, STRN4, and FKRP are reported to be expressed in the heart (http:// www.dsi.univ-paris5.fr/genatlas/, http://www.ncbi.nlm.nih. gov/). An association between two of these genes, the fukutin-related protein gene (FKRP) and the vasodilatorstimulated phosphoprotein gene (VASP), and dilated cardiomyopathy was reported. Müller et al. (2005) found evidence that dilated cardiomyopathy in human may be associated with a C826A mutation in the FKRP gene. Although mutations in this gene are mostly responsible for limb-girdle muscular dystrophy (LGMD2I), they described three siblings showing the C826A substitution and an unusual phenotype with dilated cardiomyopathy and without changes in skeletal muscles. Our preliminary results indicate that there are no differences in the FKRP sequence between BDCMP-affected and unaffected animals. Eigenthaler et al. (2003) described that a disruption of cardiac Ena-VASP protein in mice may play a crucial role in intercalated disk function at the interface between cardiac myocytes and thereby might cause dilated cardiomyopathy. However, to our knowledge no mutation in the VASP gene in any species has yet been reported to be associated with cardiomyopathy.
In conclusion, using the combined strategy of homozygosity mapping and association study, we were able to fine map the BDCMP locus to a region of about 1.0 Mb. At 2 values are plotted against the physical distance on BTA18. In total, 86 SNP markers with MAF above 20% were analyzed present we are screening recombinant animals with additional SNP markers to further narrow down the interval. In addition, we will further investigate those genes that are expressed in the cardiovascular system. It is still possible that genes with not yet known function as well as regulatory mutations or chromosomal rearrangements may play an important role in the development of BDCMP.
